| __timestamp | Jazz Pharmaceuticals plc | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 117418000 | 3243000 |
| Thursday, January 1, 2015 | 102526000 | 2472000 |
| Friday, January 1, 2016 | 105386000 | 2548000 |
| Sunday, January 1, 2017 | 110188000 | 19623000 |
| Monday, January 1, 2018 | 121544000 | 30421000 |
| Tuesday, January 1, 2019 | 127930000 | 32793999 |
| Wednesday, January 1, 2020 | 148917000 | 28304000 |
| Friday, January 1, 2021 | 440760000 | 620000 |
| Saturday, January 1, 2022 | 540517000 | 755000 |
| Sunday, January 1, 2023 | 435577000 | 1322000 |
Unleashing the power of data
In the dynamic world of biopharmaceuticals, understanding cost structures is crucial. Jazz Pharmaceuticals plc and Viridian Therapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Jazz Pharmaceuticals saw a staggering 270% increase in its cost of revenue, peaking in 2022. This reflects its aggressive expansion and investment in new therapies. In contrast, Viridian Therapeutics, Inc. experienced a more volatile journey, with costs fluctuating significantly, peaking in 2019 and then dropping sharply by 2021. This volatility could be attributed to strategic pivots or changes in operational focus. The data highlights the diverse strategies within the biopharma sector, where companies must balance innovation with cost management. As the industry evolves, these trends offer valuable insights into the financial health and strategic directions of these key players.
Cost of Revenue Trends: Johnson & Johnson vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down AbbVie Inc. and Jazz Pharmaceuticals plc's Expenses
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Bio-Techne Corporation and Viridian Therapeutics, Inc.
Cost of Revenue Comparison: Exelixis, Inc. vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Galapagos NV
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Perrigo Company plc vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Viridian Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Dyne Therapeutics, Inc. vs Viridian Therapeutics, Inc.